Anna Maria Calcagno - Concepedia

Author

Anna Maria Calcagno

Also Known As

A M Calcagno, A. Calcagno, A. M. CALCAGNO, A. M. Calcagno, A.M. Calcagno, Anna Calcagno, Anna M. Calcagno, Anna Maria Calcagno

Publications

5.5K

Citations

H-Index

Concepts

All Affiliations

Center for Cancer Research National Cancer Institute National Institutes of Health United States Department of Health and Human Services National Institute of Allergy and Infectious Diseases

About

Anna Maria Calcagno is an author at Center for Cancer Research specializing in medicine, natural sciences, and cell biology.

Top Concepts

#	Concept	H-Index	Publications	Citations
1	Engineering	2	2	36
2	Business	1	1	11
3	Health Sciences	1	1	124
4	Law	1	1	11
5	Management	1	1	11

Anna Maria Calcagno

Publications

5.1K

Citations

H-Index

Page 1

	Year	Citations
A "Silent" Polymorphism in the <i>MDR</i> 1 Gene Changes Substrate Specificity Chava Kimchi‐Sarfaty, Jung Mi Oh, In‐Wha Kim, Science	2006	2.4K
Brca1 breast tumors contain distinct CD44+/CD24- and CD133+cells with cancer stem cell characteristics Mollie H. Wright, Anna Maria Calcagno, Crystal D. Salcido, Breast Cancer Research	2008	659
Redefining the relevance of established cancer cell lines to the study of mechanisms of clinical anti-cancer drug resistance Jean-Pierre Gillet, Anna Maria Calcagno, Sudhir Varma, Proceedings of the National Academy of Sciences	2011	467
Prolonged Drug Selection of Breast Cancer Cells and Enrichment of Cancer Stem Cell Characteristics Anna Maria Calcagno, Crystal D. Salcido, Jean-Pierre Gillet, JNCI Journal of the National Cancer Institute	2010	285
Modulatory effects of plant phenols on human multidrug‐resistance proteins 1, 4 and 5 (ABCC1, 4 and 5) Chung‐Pu Wu, Anna Maria Calcagno, Stephen B. Hladky, FEBS Journal	2005	160
NIH funding longevity by gender Lisa A. Hechtman, Nathan P. Moore, Claire E. Schulkey, Proceedings of the National Academy of Sciences	2018	146
Single-step doxorubicin-selected cancer cells overexpress the ABCG2 drug transporter through epigenetic changes Anna Maria Calcagno, Jennifer Fostel, Kenneth K.W. To, British Journal of Cancer Abcg2 Drug TransporterMultidrug ResistanceCancer BiologyTumor BiologyDrug Resistance	2008	124
Evidence for dual mode of action of a thiosemicarbazone, NSC73306: a potent substrate of the multidrug resistance–linked ABCG2 transporter Chung‐Pu Wu, Suneet Shukla, Anna Maria Calcagno, Molecular Cancer Therapeutics	2007	99
Sequential use of sorafenib and sunitinib in advanced renal‐cell carcinoma (RCC): an Italian multicentre retrospective analysis of 189 patient cases Camillo Porta, Giuseppe Procopio, Giacomo Cartenì, British Journal of Urology	2011	87
Molecular Mechanisms of Drug Resistance in Single-Step and Multi-Step Drug-Selected Cancer Cells Anna Maria Calcagno, Suresh V. Ambudkar Methods in molecular biology	2009	71

Page 1